Trial Profile
A study to compare the efficacy and tolerability of lisinopril/amlodipine versus telmisartan/amlodipin combination in hypertensive patients with metabolic syndrome
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Nov 2016
Price :
$35
*
At a glance
- Drugs Amlodipine/lisinopril (Primary) ; Amlodipine/telmisartan (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 14 Nov 2016 New trial record
- 29 Sep 2016 Results presented at the 26th Scientific Meeting of the International Society of Hypertension